Primary Job Title Chief Commercial Officer Primary Organization Lineage Cell Therapeutics
Gender Male
William P. Tew, Ph.D. was appointed our Chief Commercial Officer in June 2011. Before joining BioTime, Dr. Tew was co-founder, President, and Chief Executive Officer of Glycosan BioSystems, Inc., which was acquired by BioTime’s subsidiary OrthoCyte Corporation in 2011. Dr. Tew founded Glycosan in 2006 and oversaw Glycosan’s development and
commercialization of an array of hydrogel extracellular matrix products, generating growing revenues and building a substantial base of customers at leading research universities.
In 1980, Dr. Tew founded Chesapeake Biological Laboratories (CBL), where he served as chairman and CEO for almost two decades (1981-1999), developing and manufacturing bulk pharmaceuticals, parenteral drugs, and medical devices in compliance with FDA regulations. CBL’s revenues and profits grew steadily under Dr. Tew’s leadership and the Company was acquired by Cangene Corporation for $42 million in 2001.
